Search Within

Sarcoma Service (Pediatrics)

Formats
  1. Journal Article (379)
  2. Meeting Abstract (194)
  3. Review (18)
  4. Editorial (9)
  5. Book Section (7)
  6. Correspondence (3)
  7. Guidelines (2)
  8. Research Letter (2)
Groups
  1. Pediatrics, Department of (614)
  2. Center for Hematologic Malignancies (231)
  3. Surgery (215)
  4. Pediatric Leukemia (183)
  5. Tow Center for Developmental Oncology (TCDO) (163)
  6. GSK Faculty (150)

More Groups

People
  1. Paul Meyers (311)
  2. Leonard Wexler (191)
  3. John Healey (115)
  4. Julia Glade Bender (85)
  5. Michael La Quaglia (82)
  6. Andrew Huvos (74)

More People

Years
  1. 2025 (12)
  2. 2024 (31)
  3. 2023 (32)
  4. 2022 (48)
  5. 2021 (29)
  6. 2020 (48)

More Years

Publications
  1. Pediatric Blood and Cancer (95)
  2. Journal of Clinical Oncology (90)
  3. Cancer Research (39)
  4. Cancer (31)
  5. International Journal of Radiation Oncology, Biology, Physics (30)
  6. Clinical Cancer Research (25)

More Publications

Publishers
  1. Wiley Periodicals, Inc (104)
  2. American Society of Clinical Oncology (101)
  3. American Association for Cancer Research (92)
  4. Elsevier Inc. (54)
  5. Wiley Blackwell (35)
  6. Lippincott Williams & Wilkins (30)

More Publishers

Results (614)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: A single center quality improvement initiative
    Meeting Abstract

    Satty, A.; Stiefel, J.; Bernot, M. R.; Hudda, Z.; Llaurador, G.; Lakkaraja, M.; Mauguen, A.; Seo, S.; Glade-Bender, J.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Post-chemotherapy blastemal-predominant Wilms tumor in the Children's Oncology Group (COG) context: Pooled outcomes data from studies AREN0532, AREN0533 AND AREN03B2
    Meeting Abstract

    Evageliou, N.; Renfro, L.; Vallance, K.; Varela, C.; Benedetti, D.; Perlman, E.; Cost, N.; Ehrlich, P.; Kalapurakal, J.; Khanna, G.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition
    Meeting Abstract

    Nacev, B. A.; Bradic, M.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Gundem, G.; Ossa, J. E. A.; Bouvier, N.; Dela Cruz, F. S.; Hameed, M.; Bender, J. L. G.; Tap, W. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma
    Meeting Abstract

    Avutu, V.; Slotkin, E. K.; Livingston, J. A. A.; Chawla, S. P.; Pressey, J. G.; Nandkumar, P.; Zheng, C.; Misir, S.; Pultar, P.; Voliotis, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Regulation of oncogenic transcription and tumor growth in pediatric cancers by the CDK9 inhibitor KB-0742
    Meeting Abstract

    Saffran, D.; Poon, E.; Ibanez, G.; Nakashima, J.; Amara, S. N. A.; Noe, C.; Hood, T.; Kumar, P.; DiMartino, J.; Dela Cruz, F.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: A genomic and clinicopathologic study
    Journal Article

    Dermawan, J. K.; Hwang, S.; Wexler, L.; Tap, W. D.; Singer, S.; Vanderbilt, C. M.; Antonescu, C. R.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
    Journal Article

    Coutinho, D. F.; Mundi, P. S.; Marks, L. J.; Burke, C.; Ortiz, M. V.; Diolaiti, D.; Bird, L.; Vallance, K. L.; Ibáñez, G.; You, D.; more...
    Med (2022)

    Fulltext@MSK | Save
  • Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
    Review

    Pearson, A. D.; Allen, C.; Fangusaro, J.; Hutter, C.; Witt, O.; Weiner, S.; Reaman, G.; Russo, M.; Bandopadhayay, P.; Ahsan, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save